CHICAGO, Sept 10 (Reuters) - St. Jude Medical Inc plans to gain market share in implantable cardioverter defibrillators and is still hiring staff, even as rival device makers retrench amid a market ...

CHICAGO, July 22 (Reuters) - Medical device maker St. Jude Medical Inc reported better-than-expected quarterly results on Thursday, helped by rival Boston Scientific Corp's one-month halt in shipments ...

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced CE Mark approval of expanded labelling for its Ellipse™ implantable cardioverter ...

Minnesota-based medical device company St. Jude Medical is pausing enrollment in a clinical trial for one of its more promising devices, the slender Nanostim pacemaker that fits entirely inside the ...

St. Jude Medical (NYSE:STJ) announced Monday that it has won regulatory approval from the European Union to market a smaller implantable cardioverter defibrillator. The Ellipse is the industry’s ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. St. Jude Medical Inc. has secured an exclusive option to ...

Despite its troubles related to the Riata and the Riata ST lead recalls, St. Jude Medical CEO Daniel Starks told analysts Wednesday that the company will gain a 1 percentage point market share in the ...

A patient at St. Francis Hospital in Rosyln, New York, Carol Kasyjanski, 61, has become the first recipient of St. Jude Medical's wireless-enabled pacemaker, which the FDA approved in July. Kasyjanksi ...

67 WALL STREET, New York - March 21, 2012 - The Wall Street Transcript has just published its Medical Devices Report offering a timely review of the sector to serious investors and industry executives ...

I should be dutifully reading abstracts from the European Society of Cardiology (ESC) 2012 Congress. I should be preparing for tomorrow's sessions. At the risk of turning "Trials and Fibrillations" ...

St. Jude Medical Inc. on Monday announced the acquisition of Nano­stim Inc., giving the Little Canada-based medical technology company the world's first commercially available "leadless" pacemaker.